L
Louise C. Medley
Publications - 3
Citations - 507
Louise C. Medley is an academic researcher. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 1, co-authored 1 publications receiving 454 citations.
Papers
More filters
Journal ArticleDOI
A Phase I Study of OncoVEXGM-CSF, a Second-Generation Oncolytic Herpes Simplex Virus Expressing Granulocyte Macrophage Colony-Stimulating Factor
Jennifer C.C. Hu,Robert S. Coffin,Ceri J. Davis,Nicola J. Graham,Natasha Groves,Peter J. Guest,Kevin J. Harrington,Nicholas D. James,Colin Love,Iain A. McNeish,Louise C. Medley,Agnieszka Michael,Christopher M. Nutting,Hardev Pandha,Claire A. Shorrock,Julie Simpson,Jan Steiner,Neil Steven,Dennis Wright,R. Charles Coombes +19 more
TL;DR: Onco VEXGM-CSF is well tolerated and can be safely administered using the multidosing protocol described, and evidence of an antitumor effect was seen.
Journal ArticleDOI
Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study.
Brian Nicholson,Jason Oke,P S Virdee,Dean A. Harris,Catherine A O'Doherty,Zaed Z R Hamady,Vinay Sehgal,Andrew Millar,Louise C. Medley,Sharon Tonner,Lazarina Engonidou,Kaveh Riahi,Ying Luan,Sara Hiom,Harpal S. Kumar,Kathryn N. Kurtzman,Ly-Mee Yu,Sarah Pearson,FD Richard Hobbs,Rafael Perera,Mark R. Middleton +20 more
Journal ArticleDOI
SCOT: Tumor Sidedness and the Influence of Adjuvant Chemotherapy Duration on Disease Free Survival (DFS).
Mark P Saunders,Rohan Iype,Caroline Kelly,Jana Crosby,Rachel Kerr,Andrea Harkin,Karen Allan,J Mcqueen,Sarah Pearson,Jim Cassidy,Louise C. Medley,Sherif Raouf,Mark Harrison,Alison Brewster,Charlotte Rees,Richard J. Ellis,Anne L. Thomas,Mark Churn,Timothy Iveson,N Maka +19 more
TL;DR: In this article , the authors investigated the difference in disease free survival (DFS) between colorectal patients with right and left-sided tumors in the SCOT study, and found that patients with loco-regional right-sided coloresctal tumors have a worse overall survival (OS).